Login / Signup

Use of gastric-acid suppressants may be a risk factor for enteric peritonitis in patients undergoing peritoneal dialysis: A meta-analysis.

Hao-Jie ZhongDa LinZhi-Yong LuWan-Ying YangYu Chen
Published in: Journal of clinical pharmacy and therapeutics (2018)
Gastric-acid suppressants use might be a risk factor for enteric peritonitis in PD patients. In particular, H2 RAs increased the risk of enteric peritonitis, but PPIs did not. Therefore, to prevent enteric peritonitis, H2 RAs should probably be prescribed with caution for PD patients.
Keyphrases
  • end stage renal disease
  • peritoneal dialysis
  • chronic kidney disease
  • patients undergoing
  • ejection fraction
  • newly diagnosed